UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 204

Sortiert nach

S1348 Patterns of GI Specialty Referral for Primary Care Patients With Nonalcoholic Fatty Liver Disease

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e970-e970

2022

Volltextzugriff (PDF)

Hepatic Fibrosis Risk Assessment in Primary Care: Opportunities and Challenges

Digestive diseases and sciences, 2024-07, Vol.69 (7), p.2279-2280

2024

Volltextzugriff (PDF)

S1339 Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients With Nonalcoholic Fatty Liver Disease

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e964-e965

2022

Volltextzugriff (PDF)

S1239 Utilization of Statins in Primary Care Patients With Chronic Liver Disease

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e896-e896

2022

Volltextzugriff (PDF)

Identifying Patients with Nonalcoholic Fatty Liver Disease in Primary Care: How and for What Benefit?

Journal of clinical medicine, 2023-06, Vol.12 (12), p.4001

2023

Volltextzugriff (PDF)

Trends in Healthcare Expenditures Among US Adults With Hypertension: National Estimates, 2003–2014

Journal of the American Heart Association, 2018-06, Vol.7 (11), p.n/a

2018

Volltextzugriff (PDF)

Longitudinal, Spaced-Learning POCUS Curriculum for Internal Medicine Residents to Improve Knowledge and Skills

The American journal of the medical sciences, 2022-05, Vol.363 (5), p.399-402

2022

Volltextzugriff (PDF)

Nonalcoholic Fatty Liver Disease Underdiagnosis in Primary Care: What Are We Missing?

Journal of general internal medicine : JGIM, 2022-08, Vol.37 (10), p.2587-2590

2022

Volltextzugriff (PDF)

It Is Time for Financial Wellness Curricular Interventions

Academic medicine, 2022-07, Vol.97 (7), p.940-940

2022

Volltextzugriff (PDF)

The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care

Journal of general internal medicine : JGIM, 2022-10, Vol.37 (13), p.3266-3274

2022

Volltextzugriff (PDF)

Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort

Journal of clinical gastroenterology, 2023-01, Vol.57 (1), p.89

2023

Volltextzugriff (PDF)

Patterns of gastroenterology specialty referral for primary care patients with metabolic dysfunction-associated steatotic liver disease

The American journal of the medical sciences, 2024-07

2024

Volltextzugriff (PDF)

Abnormal Liver Enzymes

Journal of general internal medicine : JGIM, 2019-09, Vol.34 (9), p.1676-1676

2019

Volltextzugriff (PDF)

Statin Prescribing Patterns in Patient-Centered Medical Home Patients With NAFLD

The American journal of managed care, 2023-08, Vol.29 (8), p.408-413

Cipriani, Allison L

2023

Volltextzugriff (PDF)

FIB‐4 and incident severe liver outcomes in patients with undiagnosed chronic liver disease: A Fine‐Gray competing risk analysis

Liver international, 2023-01, Vol.43 (1), p.170-179

2023

Volltextzugriff (PDF)

Real-World Primary Care Data Comparing ALT and FIB-4 in Predicting Future Severe Liver Disease Outcomes

Journal of general internal medicine : JGIM, 2023-08, Vol.38 (11), p.2453-2460

2023

Volltextzugriff (PDF)

Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients with Nonalcoholic Fatty Liver Disease

Digestive diseases and sciences, 2023-07, Vol.68 (7), p.2946-2953

2023

Volltextzugriff (PDF)

The Cost of Hepatitis C Testing Strategies in Primary Care Patients with Abnormal Transaminases

Journal of general internal medicine : JGIM, 2020-04, Vol.35 (4), p.1340-1342

2020

Volltextzugriff (PDF)

Chronic liver disease is not associated with statin prescription in a primary care cohort

Journal of investigative medicine, 2023-12, Vol.71 (8), p.830-837

2023

Volltextzugriff (PDF)

Advanced liver fibrosis and the metabolic syndrome in a primary care setting

Diabetes/metabolism research and reviews, 2021-11, Vol.37 (8), p.e3452-n/a

2021

Volltextzugriff (PDF)

Identifying and Linking Patients At Risk for MASLD with Advanced Fibrosis to Care in Primary Care

Journal of general internal medicine : JGIM, 2024-07

2024

Volltextzugriff (PDF)

Objective measures of cardiometabolic risk and advanced fibrosis risk progression in primary care patients with metabolic dysfunction-associated steatotic liver disease

Endocrine practice, 2024-08

2024

Volltextzugriff (PDF)

Linkage to specialty care in the hepatitis C care cascade

Journal of investigative medicine, 2021-02, Vol.69 (2), p.324-332

2021

Volltextzugriff (PDF)

Glucagon-like peptide-1 receptor agonist therapy effects on glycemic control and weight in a primary care clinic population

Journal of investigative medicine, 2024-08, p.10815589241270427

2024

Volltextzugriff (PDF)

Evaluation of abnormal liver tests in the adult asymptomatic patient

Current opinion in gastroenterology, 2018-07, Vol.34 (4), p.272-279

2018

Volltextzugriff (PDF)

1 – 25 von 204

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(181)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

S1348 Patterns of GI Specialty Referral for Primary Care Patients With Nonalcoholic Fatty Liver Disease

Hepatic Fibrosis Risk Assessment in Primary Care: Opportunities and Challenges

S1339 Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients With Nonalcoholic Fatty Liver Disease

S1239 Utilization of Statins in Primary Care Patients With Chronic Liver Disease

Identifying Patients with Nonalcoholic Fatty Liver Disease in Primary Care: How and for What Benefit?

Trends in Healthcare Expenditures Among US Adults With Hypertension: National Estimates, 2003–2014

Longitudinal, Spaced-Learning POCUS Curriculum for Internal Medicine Residents to Improve Knowledge and Skills

Nonalcoholic Fatty Liver Disease Underdiagnosis in Primary Care: What Are We Missing?

It Is Time for Financial Wellness Curricular Interventions

The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care

Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort

Patterns of gastroenterology specialty referral for primary care patients with metabolic dysfunction-associated steatotic liver disease

Abnormal Liver Enzymes

Statin Prescribing Patterns in Patient-Centered Medical Home Patients With NAFLD

FIB‐4 and incident severe liver outcomes in patients with undiagnosed chronic liver disease: A Fine‐Gray competing risk analysis

Real-World Primary Care Data Comparing ALT and FIB-4 in Predicting Future Severe Liver Disease Outcomes

Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients with Nonalcoholic Fatty Liver Disease

The Cost of Hepatitis C Testing Strategies in Primary Care Patients with Abnormal Transaminases

Chronic liver disease is not associated with statin prescription in a primary care cohort

Advanced liver fibrosis and the metabolic syndrome in a primary care setting

Identifying and Linking Patients At Risk for MASLD with Advanced Fibrosis to Care in Primary Care

Objective measures of cardiometabolic risk and advanced fibrosis risk progression in primary care patients with metabolic dysfunction-associated steatotic liver disease

Linkage to specialty care in the hepatitis C care cascade

Glucagon-like peptide-1 receptor agonist therapy effects on glycemic control and weight in a primary care clinic population

Evaluation of abnormal liver tests in the adult asymptomatic patient

Suchergebnisse filtern